ABVC BioPharma Provides ABV-1601 Update on Phase I Site Init

10.04.2023 - FREMONT, CA, April 10, 2023 (GLOBE NEWSWIRE) - via NewMediaWire - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that ... Seite 1

Related Keywords

, Howard Doong , Scott Irwin , Sinai Samuel Oschin Comprehensive Cancer Institute , Sinai Medical Center , Initiation Visit , Cedars Sinai Medical Center , Chief Executive Officer , Montgomery Asberg Depression Rating Scale ,